Valentine Capital Asset Management’s Novo Nordisk NVO Stock Holding History

Valentine Capital Asset Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-204,576	Closed	-$4.87M	–	109
2014 Q3	$4.87M	Sell	204,576 -7,850	-4%	-$181K	1.88%	23
2014 Q2	$4.91M	Buy	212,426 +23,060	+12%	+$509K	0.94%	51
2014 Q1	$4.32M	Buy	+189,366	New	+$4.03M	0.9%	49

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Valentine Capital Asset Management's NVO Position: Q4 2014 in Review

Valentine Capital Asset Management sold out of Novo Nordisk (NVO) in Q4 2014, closing a stake of 204,576 shares — an estimated $4.87M sold.

Valentine Capital Asset Management first reported a position in NVO in Q1 2014 and held it in 3 quarters. The position peaked at $4.91M in Q2 2014. 500 funds tracked by Wall St. Rank hold NVO as of Q4 2014.

Valentine Capital Asset Management reported no remaining Novo Nordisk position as of Q4 2014 after selling out during the quarter.
Valentine Capital Asset Management sold 204,576 Novo Nordisk shares in Q4 2014, an estimated $4.87M.
Valentine Capital Asset Management first reported a position in Novo Nordisk in Q1 2014 and held it in 3 quarters.
Valentine Capital Asset Management's Novo Nordisk position peaked at $4.91M in Q2 2014.
500 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2014.

Based on Valentine Capital Asset Management's 13F filing for Q4 2014, filed 12 Feb 2015.